Rare pancreatic cancer patients may live longer when treated with radiation therapy

Radiation therapy is effective in achieving local control and palliation in patients with pancreatic neuroendocrine tumors (PNTs), despite such tumors being commonly considered resistant to radiation therapy, according to a largest of its kind study in the November 15 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

PNT is a very rare form of pancreatic cancer that can stay confined to the liver and often cause death from liver damage. Since it is usually unable to be removed by surgery, external beam radiation therapy (EBRT) is an attractive option for managing the disease, but the role of EBRT is largely unknown because of the low incidence of this tumor type and, as a result, very few related studies.

Researchers at the departments of radiation oncology and internal medicine, division of hematology/oncology and comprehensive cancer center biostatistics unit at the University of Michigan in Ann Arbor, Mich., sought to determine if PNTs are not as resistant to radiation therapy as was previously thought.

Records from 36 patients with PNTs who were treated between 1986 and 2006 with radiation therapy to 49 sites were reviewed and it was found that in 39 percent of patients the tumor shrunk to less than half its pretreatment size after being treated with EBRT. Also, radiation therapy treatments achieved high rates of local control and 90 percent of patients experienced palliation of symptoms such as pain, nausea, vomiting or obstructive jaundice.

Theodore S. Lawrence, M.D., Ph.D., FASTRO, an author on the study and chair of the University of Michigan Department of Radiation Oncology, said, “While this particular type of cancer can have potentially devastating effects on a patient, this study proves that using external beam radiation therapy may permit these patients to live longer, which is a very positive breakthrough for a disease that can have very negative outcomes.”

###

ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy. For more information on radiation therapy, visit http://www.rtanswers.org. To learn more about ASTRO, visit http://www.astro.org. 

RELATED STORIES:
Herbal remedy shown to have anti-cancer effect   Popular herbal supplement hinders the growth of pancreatic cancer cells   Link Found Between Periodontal Disease and Pancreatic Cancer   Drug slows prostate tumor growth by keeping vitamin A active   Gene therapy tested in pancreatic cancer studies   New drug achieves pancreatic cancer tumor remission and prevents recurrence   A tumor of the pancreas mimicked by colonic duplication?   New Treatment for Pancreatic Cancer Allows Life-Saving Surgery   An Herbal Extract Inhibits the Development of Pancreatic Cancer   Study links sugary soft drinks to pancreatic cancer   New research improves early detection and survival for pancreatic cancer   Burned meat linked to pancreatic cancer   Vitamin D May Cut Pancreatic Cancer Risk by Nearly Half   Nanoscopic changes to pancreatic cells reveal cancer   New treatment combination safe for pancreatic cancer patients   Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy   Gene Discovered by Researchers Tied to Pancreatic Cancer   Ingredient in red chili pepper has cancer-fighting properties   Pancreatic cancer vaccine may improve survival   No support for routine pancreatic cancer screening   A promising approach in the prevention and treatment of pancreatic cancer   Blood pressure drugs halt pancreatic cancer cell growth, Jefferson researchers find

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]